Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

NCT04523831 (Mahmud), 2020 NCT04523831

ivermectin plus doxycycline (n=200) vs. standard of care (n=200)

randomized controlled trial   some concerns about risk of bias

Studied treatment

Ivermectin and Doxycycline
Ivermectin 6 mg, 2 tab stat and Doxycycline 100 mg twice daily for 5 days

Control treatment

standard of care

Patients

COVID-19 mild to moderate

Method

double blind

1 center, Bangladesh

Remark